220 related articles for article (PubMed ID: 14515274)
21. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects.
Dwivedi Y; Rizavi HS; Teppen T; Sasaki N; Chen H; Zhang H; Roberts RC; Conley RR; Pandey GN
Neuropsychopharmacology; 2007 Nov; 32(11):2338-50. PubMed ID: 17342168
[TBL] [Abstract][Full Text] [Related]
22. Role of activator protein 1, nuclear factor-kappaB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells.
Lorentz A; Klopp I; Gebhardt T; Manns MP; Bischoff SC
J Allergy Clin Immunol; 2003 May; 111(5):1062-8. PubMed ID: 12743571
[TBL] [Abstract][Full Text] [Related]
23. MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.
Sun W; Wei X; Kesavan K; Garrington TP; Fan R; Mei J; Anderson SM; Gelfand EW; Johnson GL
Mol Cell Biol; 2003 Apr; 23(7):2298-308. PubMed ID: 12640115
[TBL] [Abstract][Full Text] [Related]
24. WNK1 activates ERK5 by an MEKK2/3-dependent mechanism.
Xu BE; Stippec S; Lenertz L; Lee BH; Zhang W; Lee YK; Cobb MH
J Biol Chem; 2004 Feb; 279(9):7826-31. PubMed ID: 14681216
[TBL] [Abstract][Full Text] [Related]
25. MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression.
Su B; Cheng J; Yang J; Guo Z
J Biol Chem; 2001 May; 276(18):14784-90. PubMed ID: 11278622
[TBL] [Abstract][Full Text] [Related]
26. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases.
Zhao M; Liu Y; Bao M; Kato Y; Han J; Eaton JW
Arch Biochem Biophys; 2002 Apr; 400(2):199-207. PubMed ID: 12054430
[TBL] [Abstract][Full Text] [Related]
27. Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway.
Terasawa K; Okazaki K; Nishida E
Genes Cells; 2003 Mar; 8(3):263-73. PubMed ID: 12622723
[TBL] [Abstract][Full Text] [Related]
28. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
[TBL] [Abstract][Full Text] [Related]
29. A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway.
Seyfried J; Wang X; Kharebava G; Tournier C
Mol Cell Biol; 2005 Nov; 25(22):9820-8. PubMed ID: 16260599
[TBL] [Abstract][Full Text] [Related]
30. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
[TBL] [Abstract][Full Text] [Related]
31. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
33. [Involvement of ERK5 and JNK in the BMP9-induced differentiation of C3H10T1/2 cells into cardiomyocyte-like cells].
Geng X; Liu S; Chen Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):829-32, 840. PubMed ID: 25108436
[TBL] [Abstract][Full Text] [Related]
34. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
Barros JC; Marshall CJ
J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
[TBL] [Abstract][Full Text] [Related]
35. The stress kinase mitogen-activated protein kinase kinase (MKK)7 is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells.
Sasaki T; Wada T; Kishimoto H; Irie-Sasaki J; Matsumoto G; Goto T; Yao Z; Wakeham A; Mak TW; Suzuki A; Cho SK; Zuniga-Pflucker JC; Oliveira-dos-Santos AJ; Katada T; Nishina H; Penninger JM
J Exp Med; 2001 Sep; 194(6):757-68. PubMed ID: 11560992
[TBL] [Abstract][Full Text] [Related]
36. Mip1, an MEKK2-interacting protein, controls MEKK2 dimerization and activation.
Cheng J; Zhang D; Kim K; Zhao Y; Zhao Y; Su B
Mol Cell Biol; 2005 Jul; 25(14):5955-64. PubMed ID: 15988011
[TBL] [Abstract][Full Text] [Related]
37. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.
Tatake RJ; O'Neill MM; Kennedy CA; Wayne AL; Jakes S; Wu D; Kugler SZ; Kashem MA; Kaplita P; Snow RJ
Biochem Biophys Res Commun; 2008 Dec; 377(1):120-5. PubMed ID: 18834865
[TBL] [Abstract][Full Text] [Related]
38. The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells.
Akaike M; Che W; Marmarosh NL; Ohta S; Osawa M; Ding B; Berk BC; Yan C; Abe J
Mol Cell Biol; 2004 Oct; 24(19):8691-704. PubMed ID: 15367687
[TBL] [Abstract][Full Text] [Related]
39. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation.
Cheng J; Yang J; Xia Y; Karin M; Su B
Mol Cell Biol; 2000 Apr; 20(7):2334-42. PubMed ID: 10713157
[TBL] [Abstract][Full Text] [Related]
40. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
Feoktistov I; Goldstein AE; Biaggioni I
Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
